Abstract
Chronic stable angina is the most prevalent symptom of ischaemic heart disease and its management is a priority. Current guidelines recommend pharmacological therapy with drugs classified as being first line (beta blockers, calcium channel blockers, short acting nitrates) or second line (long-acting nitrates, ivabradine, nicorandil, ranolazine, and trimetazidine). Second line drugs are indicated for patients who have contraindications to first line agents, do not tolerate them or remain symptomatic. Evidence that one drug is superior to another has been questioned. Between January and March 2018, we performed a systematic review of articles written in English over the past 50 years English-written articles in Medline and Embase following preferred reporting items and the Cochrane collaboration approach. We included double blind randomized studies comparing parallel groups on treatment of angina in patients with stable coronary artery disease, with a sample size of, at least, 100 patients (50 patients per group), with a minimum follow-up of 1 week and an outcome measured on exercise testing, duration of exercise being the preferred outcome. Thirteen studies fulfilled our criteria. Nine studies involved between 100 and 300 patien...Continue Reading
References
Jan 1, 1992·Journal of Cardiovascular Pharmacology·R van der DoesB Ehmer
Jan 1, 1990·European Journal of Clinical Pharmacology·D JainE B Raftery
Jan 1, 1987·Drugs·R Berlin
Jan 1, 1981·Journal of Cardiovascular Pharmacology·K SakaiH Nabata
Jun 1, 1995·Journal of the American College of Cardiology·D ArdissinoI Wahlqvist
Mar 1, 1994·British Journal of Clinical Pharmacology·J M DetryP Mathes
Jul 1, 1993·European Heart Journal·J L GuermonprezF Peterlongo
Jan 1, 1996·European Heart Journal·K M FoxH J Dargie
Jan 1, 1997·European Journal of Clinical Pharmacology·U Hauf-ZachariouE Pfarr
Nov 4, 2000·Clinical Cardiology·S K PehrssonS Persson
Sep 19, 1964·British Medical Journal·S C SRIVASTAVAD J NEWELL
Jan 8, 2005·Acta Cardiologica·Nevres KoylanUNKNOWN TTS Group
Jan 27, 2005·The American Journal of Cardiology·Michel F RousseauAndrew A Wolff
Oct 11, 2005·European Heart Journal·Jean-Claude TardifUNKNOWN INITIATIVE Investigators
Apr 28, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·J P Vilaine
Mar 6, 2007·Drugs·Witold RuzylloKim M Fox
May 29, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Wen-Ling ZhuKai You
Sep 3, 2013·European Heart Journal·UNKNOWN Task Force MembersJose Luis Zamorano
Apr 24, 2014·Pharmacoepidemiology and Drug Safety·Yan LiYouhong Jia
Citations
Jan 8, 2019·European Heart Journal·Thomas F Lüscher
May 24, 2019·Expert Opinion on Drug Safety·Jiaying LiWei Mao
Apr 19, 2019·European Heart Journal Supplements : Journal of the European Society of Cardiology·Roberto FerrariCristina Balla
May 28, 2019·European Cardiology·Talla A Rousan, Udho Thadani
Mar 11, 2020·European Heart Journal. Cardiovascular Pharmacotherapy·Roberto Ferrari, Giuseppe Rosano
May 21, 2020·Cardiology and Therapy·Maria G GlezerUNKNOWN ODA investigators
Aug 28, 2020·Molecular and Cellular Biochemistry·Muhammad Afzal
Aug 28, 2020·Frontiers in Pharmacology·Yong YangHong Wang
Aug 11, 2019·Current Topics in Medicinal Chemistry·Yue ZhouKun Sun
Nov 19, 2019·European Heart Journal Supplements : Journal of the European Society of Cardiology·Roberto FerrariA Squeri
Dec 14, 2019·Indian Journal of Pharmacology·Lamiaa Ahmed Ahmed
Mar 17, 2020·Current Problems in Cardiology·Roberto FerrariGiuseppe Rosano
May 7, 2019·European Heart Journal·Thomas F Lüscher
Dec 29, 2020·European Heart Journal·Allan DaviesThomas F Lüscher
Nov 15, 2020·European Heart Journal·Roberto FerrariPaolo Cimaglia
May 13, 2021·Cardiovascular Drugs and Therapy·Colin BerryCarl J Pepine
Jun 12, 2021·International Journal of General Medicine·Roberto C Cerrud-RodriguezJose Wiley
Jul 9, 2021·Nature Reviews. Cardiology·Edoardo BerteroChristoph Maack
Jul 22, 2021·The FEBS Journal·Ling WuLiang Zhao
May 12, 2021·The Canadian Journal of Cardiology·Guglielmo GalloneGaetano Maria De Ferrari
Nov 19, 2021·Expert Opinion on Pharmacotherapy·Jayakumar SreenivasanWilbert S Aronow
Dec 1, 2021·Advances in Therapy·Lan ShenNing Zhou
Nov 30, 2021·Future Cardiology·Juan Tamargo, Jose Lopez-Sendon
Dec 28, 2021·Cardiology and Therapy·Yuri LopatinUNKNOWN MODUS VIVENDI investigators